Technical Analysts See Bullish Signs for Biotech ETFs

After a sharp sell-off in March and languish trading through May, the biotechnology sector and related exchange traded funds are looking to break out. The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), which tracks biotech and pharma stocks on the Nasdaq, fell 9.6% over the past three months,...